Distinguishing Fibrinogen Molecular Effects from Copurified Components in Functional Transfer Experiments: A proposed framework for purification component perturbation and plasma reconstitution

A functional phenotype that accompanies a purified fibrinogen preparation does not, by itself, establish that its cause is intrinsic to fibrinogen. Associated proteins, residual inhibitors, cofactors, and processing-induced changes may influence clot formation and fibrinolysis. This methodological article proposes an experimental framework for distinguishing fibrinogen molecular properties from the contributions of copurified components. It combines orthogonal purification, molecular characterization, targeted residual-component measurements, controlled depletion and add-back, and crossed plasma reconstitution. Particular attention is given to factor XIII, plasminogen, and α2-antiplasmin, distinguishing their abundance, activity, activation, and incorporation into fibrin. The framework interprets analytical non-detection within demonstrated sensitivity and functional relevance, while recognizing that additional purification may remove an active component or alter the fibrinogen state under investigation. A two-by-two reconstitution design separates effects associated with fibrinogen-preparation origin, plasma background, and their interaction. Statistical planning preserves donor-level independence, accounts for repeated measurements and batch structure, and distinguishes imprecise findings from evidence against a predefined relevant effect. Four tables and two practical planning records connect experimental controls to bounded conclusions and GO/MODIFY/NO-GO decisions. The framework accommodates simultaneous contributions from fibrinogen properties and associated components rather than assuming mutually exclusive mechanisms. No original experimental or participant results are reported. The proposed framework and planning instruments require prospective evaluation. Their purpose is to guide increasingly specific molecular attribution without equating phenotype transfer with intrinsic fibrinogen causality, clinical disease causation, or self-sustaining pathological memory.